0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Early Detection and Screening Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18Z14799
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Early Detection and Screening Market Research Report 2023
BUY CHAPTERS

Global Cancer Early Detection and Screening Market Research Report 2025

Code: QYRE-Auto-18Z14799
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cancer Early Detection and Screening Market Size

The global market for Cancer Early Detection and Screening was valued at US$ 274 million in the year 2024 and is projected to reach a revised size of US$ 417 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Cancer Early Detection and Screening Market

Cancer Early Detection and Screening Market

Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.
North American market for Cancer Early Detection and Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Early Detection and Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Early Detection and Screening in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Early Detection and Screening include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection and Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection and Screening.
The Cancer Early Detection and Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Early Detection and Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Early Detection and Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Early Detection and Screening Market Report

Report Metric Details
Report Name Cancer Early Detection and Screening Market
Accounted market size in year US$ 274 million
Forecasted market size in 2031 US$ 417 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Medical Center
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Early Detection and Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Early Detection and Screening Market growing?

Ans: The Cancer Early Detection and Screening Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Cancer Early Detection and Screening Market size in 2031?

Ans: The Cancer Early Detection and Screening Market size in 2031 will be US$ 417 million.

Who are the main players in the Cancer Early Detection and Screening Market report?

Ans: The main players in the Cancer Early Detection and Screening Market are Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical

What are the Application segmentation covered in the Cancer Early Detection and Screening Market report?

Ans: The Applications covered in the Cancer Early Detection and Screening Market report are Hospital, Medical Center, Other

What are the Type segmentation covered in the Cancer Early Detection and Screening Market report?

Ans: The Types covered in the Cancer Early Detection and Screening Market report are Colorectal Cancer, Liver Cancer, Lung Cancer, Other

Recommended Reports

Cancer Diagnostics

Screening Devices & Tests

Cancer Genomics & Markers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Early Detection and Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Early Detection and Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Early Detection and Screening Market Perspective (2020-2031)
2.2 Global Cancer Early Detection and Screening Growth Trends by Region
2.2.1 Global Cancer Early Detection and Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Early Detection and Screening Historic Market Size by Region (2020-2025)
2.2.3 Cancer Early Detection and Screening Forecasted Market Size by Region (2026-2031)
2.3 Cancer Early Detection and Screening Market Dynamics
2.3.1 Cancer Early Detection and Screening Industry Trends
2.3.2 Cancer Early Detection and Screening Market Drivers
2.3.3 Cancer Early Detection and Screening Market Challenges
2.3.4 Cancer Early Detection and Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Early Detection and Screening Players by Revenue
3.1.1 Global Top Cancer Early Detection and Screening Players by Revenue (2020-2025)
3.1.2 Global Cancer Early Detection and Screening Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Early Detection and Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Early Detection and Screening Revenue
3.4 Global Cancer Early Detection and Screening Market Concentration Ratio
3.4.1 Global Cancer Early Detection and Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection and Screening Revenue in 2024
3.5 Global Key Players of Cancer Early Detection and Screening Head office and Area Served
3.6 Global Key Players of Cancer Early Detection and Screening, Product and Application
3.7 Global Key Players of Cancer Early Detection and Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Early Detection and Screening Breakdown Data by Type
4.1 Global Cancer Early Detection and Screening Historic Market Size by Type (2020-2025)
4.2 Global Cancer Early Detection and Screening Forecasted Market Size by Type (2026-2031)
5 Cancer Early Detection and Screening Breakdown Data by Application
5.1 Global Cancer Early Detection and Screening Historic Market Size by Application (2020-2025)
5.2 Global Cancer Early Detection and Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Early Detection and Screening Market Size (2020-2031)
6.2 North America Cancer Early Detection and Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Early Detection and Screening Market Size by Country (2020-2025)
6.4 North America Cancer Early Detection and Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Early Detection and Screening Market Size (2020-2031)
7.2 Europe Cancer Early Detection and Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Early Detection and Screening Market Size by Country (2020-2025)
7.4 Europe Cancer Early Detection and Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection and Screening Market Size (2020-2031)
8.2 Asia-Pacific Cancer Early Detection and Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Early Detection and Screening Market Size (2020-2031)
9.2 Latin America Cancer Early Detection and Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Early Detection and Screening Market Size by Country (2020-2025)
9.4 Latin America Cancer Early Detection and Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection and Screening Market Size (2020-2031)
10.2 Middle East & Africa Cancer Early Detection and Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Details
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Cancer Early Detection and Screening Introduction
11.1.4 Exact Sciences Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.1.5 Exact Sciences Recent Development
11.2 Grail
11.2.1 Grail Company Details
11.2.2 Grail Business Overview
11.2.3 Grail Cancer Early Detection and Screening Introduction
11.2.4 Grail Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.2.5 Grail Recent Development
11.3 Genetron Health
11.3.1 Genetron Health Company Details
11.3.2 Genetron Health Business Overview
11.3.3 Genetron Health Cancer Early Detection and Screening Introduction
11.3.4 Genetron Health Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.3.5 Genetron Health Recent Development
11.4 New Horizon Health
11.4.1 New Horizon Health Company Details
11.4.2 New Horizon Health Business Overview
11.4.3 New Horizon Health Cancer Early Detection and Screening Introduction
11.4.4 New Horizon Health Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.4.5 New Horizon Health Recent Development
11.5 Burning Rock
11.5.1 Burning Rock Company Details
11.5.2 Burning Rock Business Overview
11.5.3 Burning Rock Cancer Early Detection and Screening Introduction
11.5.4 Burning Rock Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.5.5 Burning Rock Recent Development
11.6 Berry Oncology
11.6.1 Berry Oncology Company Details
11.6.2 Berry Oncology Business Overview
11.6.3 Berry Oncology Cancer Early Detection and Screening Introduction
11.6.4 Berry Oncology Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.6.5 Berry Oncology Recent Development
11.7 Shanghai Kunyuan Biotechnology
11.7.1 Shanghai Kunyuan Biotechnology Company Details
11.7.2 Shanghai Kunyuan Biotechnology Business Overview
11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Introduction
11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.7.5 Shanghai Kunyuan Biotechnology Recent Development
11.8 Oncognostic
11.8.1 Oncognostic Company Details
11.8.2 Oncognostic Business Overview
11.8.3 Oncognostic Cancer Early Detection and Screening Introduction
11.8.4 Oncognostic Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.8.5 Oncognostic Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Details
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Cancer Early Detection and Screening Introduction
11.9.4 Epigenomics Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.9.5 Epigenomics Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Cancer Early Detection and Screening Introduction
11.10.4 Abbott Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.10.5 Abbott Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cancer Early Detection and Screening Introduction
11.11.4 Qiagen Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.11.5 Qiagen Recent Development
11.12 iStat Biomedical
11.12.1 iStat Biomedical Company Details
11.12.2 iStat Biomedical Business Overview
11.12.3 iStat Biomedical Cancer Early Detection and Screening Introduction
11.12.4 iStat Biomedical Revenue in Cancer Early Detection and Screening Business (2020-2025)
11.12.5 iStat Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cancer Early Detection and Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Colorectal Cancer
 Table 3. Key Players of Liver Cancer
 Table 4. Key Players of Lung Cancer
 Table 5. Key Players of Other
 Table 6. Global Cancer Early Detection and Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancer Early Detection and Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Cancer Early Detection and Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Cancer Early Detection and Screening Market Share by Region (2020-2025)
 Table 10. Global Cancer Early Detection and Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Cancer Early Detection and Screening Market Share by Region (2026-2031)
 Table 12. Cancer Early Detection and Screening Market Trends
 Table 13. Cancer Early Detection and Screening Market Drivers
 Table 14. Cancer Early Detection and Screening Market Challenges
 Table 15. Cancer Early Detection and Screening Market Restraints
 Table 16. Global Cancer Early Detection and Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Cancer Early Detection and Screening Market Share by Players (2020-2025)
 Table 18. Global Top Cancer Early Detection and Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Screening as of 2024)
 Table 19. Ranking of Global Top Cancer Early Detection and Screening Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Cancer Early Detection and Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Cancer Early Detection and Screening, Headquarters and Area Served
 Table 22. Global Key Players of Cancer Early Detection and Screening, Product and Application
 Table 23. Global Key Players of Cancer Early Detection and Screening, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Cancer Early Detection and Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Cancer Early Detection and Screening Revenue Market Share by Type (2020-2025)
 Table 27. Global Cancer Early Detection and Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Cancer Early Detection and Screening Revenue Market Share by Type (2026-2031)
 Table 29. Global Cancer Early Detection and Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Cancer Early Detection and Screening Revenue Market Share by Application (2020-2025)
 Table 31. Global Cancer Early Detection and Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Cancer Early Detection and Screening Revenue Market Share by Application (2026-2031)
 Table 33. North America Cancer Early Detection and Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Cancer Early Detection and Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Cancer Early Detection and Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Cancer Early Detection and Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Cancer Early Detection and Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Cancer Early Detection and Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Cancer Early Detection and Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Cancer Early Detection and Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Cancer Early Detection and Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Early Detection and Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Cancer Early Detection and Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Exact Sciences Company Details
 Table 49. Exact Sciences Business Overview
 Table 50. Exact Sciences Cancer Early Detection and Screening Product
 Table 51. Exact Sciences Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 52. Exact Sciences Recent Development
 Table 53. Grail Company Details
 Table 54. Grail Business Overview
 Table 55. Grail Cancer Early Detection and Screening Product
 Table 56. Grail Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 57. Grail Recent Development
 Table 58. Genetron Health Company Details
 Table 59. Genetron Health Business Overview
 Table 60. Genetron Health Cancer Early Detection and Screening Product
 Table 61. Genetron Health Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 62. Genetron Health Recent Development
 Table 63. New Horizon Health Company Details
 Table 64. New Horizon Health Business Overview
 Table 65. New Horizon Health Cancer Early Detection and Screening Product
 Table 66. New Horizon Health Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 67. New Horizon Health Recent Development
 Table 68. Burning Rock Company Details
 Table 69. Burning Rock Business Overview
 Table 70. Burning Rock Cancer Early Detection and Screening Product
 Table 71. Burning Rock Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 72. Burning Rock Recent Development
 Table 73. Berry Oncology Company Details
 Table 74. Berry Oncology Business Overview
 Table 75. Berry Oncology Cancer Early Detection and Screening Product
 Table 76. Berry Oncology Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 77. Berry Oncology Recent Development
 Table 78. Shanghai Kunyuan Biotechnology Company Details
 Table 79. Shanghai Kunyuan Biotechnology Business Overview
 Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Product
 Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 82. Shanghai Kunyuan Biotechnology Recent Development
 Table 83. Oncognostic Company Details
 Table 84. Oncognostic Business Overview
 Table 85. Oncognostic Cancer Early Detection and Screening Product
 Table 86. Oncognostic Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 87. Oncognostic Recent Development
 Table 88. Epigenomics Company Details
 Table 89. Epigenomics Business Overview
 Table 90. Epigenomics Cancer Early Detection and Screening Product
 Table 91. Epigenomics Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 92. Epigenomics Recent Development
 Table 93. Abbott Company Details
 Table 94. Abbott Business Overview
 Table 95. Abbott Cancer Early Detection and Screening Product
 Table 96. Abbott Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 97. Abbott Recent Development
 Table 98. Qiagen Company Details
 Table 99. Qiagen Business Overview
 Table 100. Qiagen Cancer Early Detection and Screening Product
 Table 101. Qiagen Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 102. Qiagen Recent Development
 Table 103. iStat Biomedical Company Details
 Table 104. iStat Biomedical Business Overview
 Table 105. iStat Biomedical Cancer Early Detection and Screening Product
 Table 106. iStat Biomedical Revenue in Cancer Early Detection and Screening Business (2020-2025) & (US$ Million)
 Table 107. iStat Biomedical Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Cancer Early Detection and Screening Picture
 Figure 2. Global Cancer Early Detection and Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Early Detection and Screening Market Share by Type: 2024 VS 2031
 Figure 4. Colorectal Cancer Features
 Figure 5. Liver Cancer Features
 Figure 6. Lung Cancer Features
 Figure 7. Other Features
 Figure 8. Global Cancer Early Detection and Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Cancer Early Detection and Screening Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Medical Center Case Studies
 Figure 12. Other Case Studies
 Figure 13. Cancer Early Detection and Screening Report Years Considered
 Figure 14. Global Cancer Early Detection and Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Cancer Early Detection and Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Cancer Early Detection and Screening Market Share by Region: 2024 VS 2031
 Figure 17. Global Cancer Early Detection and Screening Market Share by Players in 2024
 Figure 18. Global Top Cancer Early Detection and Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Screening as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Cancer Early Detection and Screening Revenue in 2024
 Figure 20. North America Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Cancer Early Detection and Screening Market Share by Country (2020-2031)
 Figure 22. United States Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cancer Early Detection and Screening Market Share by Country (2020-2031)
 Figure 26. Germany Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cancer Early Detection and Screening Market Share by Region (2020-2031)
 Figure 34. China Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cancer Early Detection and Screening Market Share by Country (2020-2031)
 Figure 42. Mexico Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cancer Early Detection and Screening Market Share by Country (2020-2031)
 Figure 46. Turkey Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Cancer Early Detection and Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Exact Sciences Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 50. Grail Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 51. Genetron Health Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 52. New Horizon Health Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 53. Burning Rock Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 54. Berry Oncology Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 55. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 56. Oncognostic Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 57. Epigenomics Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 58. Abbott Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 59. Qiagen Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 60. iStat Biomedical Revenue Growth Rate in Cancer Early Detection and Screening Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart